Sponsor content
3 result(s) found, displaying 1 to 3
-
Mar-2025Prescription medicine evaluationActive ingredient: Orelabrutinib.
-
Designation or determinationOrphan drug
-
Designation or determinationProvisional determination
Innocare Pharma Australia Pty Ltd
Regulatory activities for this sponsor.